Diabetes mellitus medication | Medication prescription rates in 2004 per 100,000 persons (95% CI) | Medication prescription rates in 2020 per 100,000 persons (95% CI) | % Change from 2004—2020 | Average change per year |
---|---|---|---|---|
“Short-acting insulins” | 1986.86 (1983.12–1990.60) | 4456.35 (4451.11–4461.58) | 124.3% | 7.8% |
“Intermediate and long-acting insulins” | 6441.32 (6434.74–6447.90) | 9013.70 (9006.44–9020.97) | 39.9% | 2.5% |
“Sulphonylureas” | 10817.13 (10808.80–10825.46) | 13355.52 (13346.89–13364.14) | 23.5% | 1.5% |
“Biguanides” | 14937.54 (14927.98–14947.10) | 39928.28 (39915.86–39940.71) | 167.3% | 10.5% |
“Other antidiabetics” | 2907.30 (2902.79–2911.81) | 21203.02(21192.65–21213.39) | 629.3% | 39.3% |
“Treatment of hypoglycaemia” | 325.46 (323.94–326.99) | 597.39 (595.43–599.34) | 83.5% | 5.2% |
“Diagnostic and monitoring agents for diabetes mellitus” | 11792.75 (11784.10–11801.40) | 12752.60 (12744.14–12761.06) | 8.1% | 0.5% |